描述 |
Nefazodone 盐酸盐是一种抗抑郁药物。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
溶解度 |
体外:
DMSO:17.5 mg / mL(34.55 mM;需要超声波和加热)
|
||||||||||||
储备液 |
|
||||||||||||
存储 |
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O=C1N(CCCN2CCN(C3=CC=CC(Cl)=C3)CC2)N=C(CC)N1CCOC4=CC=CC=C4.[H]Cl |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
盐酸异丙肾上腺素 | ICI 118,551盐酸盐 | 肉叶云香碱 | 盐酸去氧肾上腺素 | 盐酸育亨宾 | 2-胺基-5-(4-硝基苯磺酰)-噻唑 | 肾上腺素 | 盐酸伊伐布雷定 | 哌唑嗪 盐酸盐 | 5-羟基色胺盐酸盐 | 盐酸克仑特罗 | 3-甲氧基-4-羟基肉桂酸钠 | 盐酸硫利达嗪 | 依匹哌唑 | 甲磺酸酚妥拉明 |
沸点 | 599.6?C at 760 mmHg |
---|---|
熔点 | 186-188?C |
分子式 | C25H33Cl2N5O2 |
分子量 | 506.46800 |
闪点 | 316.4?C |
精确质量 | 505.20100 |
PSA | 55.53000 |
LogP | 4.35680 |
外观性状 | 白色固体 |
储存条件 | Desiccate at RT |
水溶解性 | DMSO: ~11?mg/mL at?60?°C |
|
个人防护装备 |
Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter |
---|---|
安全声明 (欧洲) |
22-24/25 |
危险品运输编码 | NONH for all modes of transport |
WGK德国 | 3 |
~63%
萘法唑酮盐酸盐
82752-99-6
|
文献:Mead Johnson and Company Patent: US4487773 A1, 1984 ; US 4487773 A |
Systematic evaluation of commercially available ultra-high performance liquid chromatography columns for drug metabolite profiling: optimization of chromatographic peak capacity. J. Chromatogr. A. 1374 , 122-33, (2014)
The present study investigated the practical use of modern ultra-high performance liquid chromatography (UHPLC) separation techniques for drug metabolite profiling, aiming to develop a widely applicab…
|
|
The relation between changes in patients’ interpersonal impact messages and outcome in treatment for chronic depression. J. Consult. Clin. Psychol. 80(3) , 354-64, (2012)
Interpersonal theories posit that chronically depressed individuals have hostile and submissive styles in their social interactions, which may undermine their interpersonal effectiveness and maintain …
|
|
Comparison of the bioactivation potential of the antidepressant and hepatotoxin nefazodone with aripiprazole, a structural analog and marketed drug. Drug Metab. Dispos. 36(6) , 1016-29, (2008)
In vitro metabolism/bioactivation of structurally related central nervous system agents nefazodone (hepatotoxin) and aripiprazole (nonhepatotoxin) were undertaken in human liver microsomes in an attem…
|
|
MFCD00865396 |
2-[3-[4-(3-chlorophenyl)piperazin-1-yl]propyl]-5-ethyl-4-(2-phenoxyethyl)-1,2,4-triazol-3-one,hydrochloride |
Nefazodone Hydrochloride |